Dangerous blood clots increased with newer antipsychotic drugs

Sep 23, 2010

Taking newer types of antipsychotic drugs could increase a person’s risk of developing dangerous blood clots, according to a new University of Nottingham study published on bmj.com today.

Venous thromboembolism — a collective term for deep vein and — is an important and preventable cause of illness and death. Up to a quarter of affected patients die within a week and almost a third of survivors experience long-term effects.

There is already limited evidence that antipsychotic drugs, some of which are also prescribed for nausea, vomiting and vertigo, may be associated with an increased risk of .

Previous studies, however, have been small and restricted to certain population groups, or have not included newer ‘atypical’ antipsychotic drugs.

Researchers from The University of Nottingham and the Nottinghamshire County Teaching Primary Care Trust examined how these drugs affected people taking them, looking at the type of drug used, and the potency and dose involved.

Data for this study came from the UK QResearch primary care database, which holds the anonymised primary care clinical records of more than 11 million people registered at any time in the past 16 years with 525 UK general practices.

The Nottingham researchers, led by Professor Julia Hippisley-Cox at The University of Nottingham, looked at 25,532 eligible cases — 15,975 with and 9,557 pulmonary embolism — recorded between 1996 and 2007 in people aged between 16 and 100.

The cases were compared with 89,491 controls and showed that people prescribed antipsychotics in the previous 24 months had a 32 per cent greater risk of venous thromboembolism than non-users, even after adjusting for potential risk factors.

Risks were higher for new users, the researchers found, as patients who had started a new drug in the previous three months, had about twice the risk.

The risk was even greater for individuals prescribed atypical rather than conventional drugs. It also tended to be greater for patients prescribed low rather than high potency drugs.

However, the authors point out that the absolute risks were low, with an excess of four extra cases of venous thromboembolism per 10,000 patients treated over one year in patients of all ages, and 10 for patients aged 65 and over.

They conclude: “Though these findings add to the accumulating evidence of adverse health events associated with antipsychotic drugs, they should be confirmed with other data sources.

“If other studies replicate these findings, antipsychotic drugs should be used more cautiously for nausea and agitation etc, especially among patients at high risk of thromboembolism. Patients need information on the balance of risks and benefits of these drugs before they start treatment.”

In an accompanying editorial, geriatrics experts Rosa Liperoti and Giovanni Gambassi argue that a higher risk means treatment should be tailored according to individual risk factors.

“In clinical practice we need to be able to identify the best candidates for antipsychotic treatment … and those who may be more susceptible to developing side effects as a result of individual vascular risk factors possibly interacting with antipsychotics,” they say.

Explore further: Bangladesh jails three over drug scam that killed hundreds of children (Update)

More information: URL for the paper: www.bmj.com/cgi/doi/10.1136/bmj.c4245

add to favorites email to friend print save as pdf

Related Stories

Bowel disease link to blood clots

Feb 10, 2010

People living with Inflammatory Bowel Disease (IBD) are known to be at high risk of blood clots when admitted to hospital during a flare-up of their disease but now new research by scientists at The University of Nottingham ...

Recommended for you

Supermaterial gives rejected drugs a new chance

Jul 22, 2014

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments : 0